MapLight Therapeutics, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | – | – | – | |
| – | -3.1% | +26.1% | -17.5% | |
| – | – | – | – | |
| – | +18.5% | -250.2% | – | |
| – | -38.1% | +66.7% | -38.6% | |
| – | -38.1% | +17,386.6% | +300.1% | |
| – | +215.2% | +12.9% | +298.0% | |
| – | +88.3% | -179.7% | – | |
| – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.